Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: Am J Transplant. 2011 Jun;11(6):1236–1247. doi: 10.1111/j.1600-6143.2011.03566.x

Figure 5.

Figure 5

Lack of killing of donor RTECs by patient NK cell-depleted PBMC in a Cr51 realease cytotoxicity assay. (A) Patient 2, third party and donor responses to donor RTEC targets; (B) Patient 1, third party and donor responses to donor RTECs. (C) Patient 5, third party and donor responses to donor RTECs.